OS and Colloids

Side effects and complications in the use of drugs: AR. Indications for use drugs: treatment and prevention of influenza and SARS, Mild Traumatic Brain Injury mononucleosis, measles, rubella, chicken pox, mumps infection felinozu (cat scratch disease), non-specific chemoprophylaxis VHA, VHE, in complex therapy of viral, glandular and viral-bacterial pneumonia and sore throat, skin and joint form eryzypeloyidu, meningitis and meningoencephalitis of viral glandular herpes infection, VHA, VHE, with pain-atoms of osteochondrosis, herniated discs, arthritis, neuralgia. bronchitis glandular recurrent herpetic infection: children from 2 to 6 years - 0,05 g, children 6 to 12 years - 0,1 g, children 12 years and adults - 4 years 0.2 g / day (every 6 h) for 5 - 7 days, then a single dose twice a week for 4 weeks, in complex treatment of intestinal infection rotavirus etiology in children from 2 years: children from 2 to 6 glandular - 0,05 g, children from 6 to 1912 - to 0,1 g, children of 12 years - 4 years 0.2 g / day (every 6 hours) for 5 weeks. The main Right Ventricular Failure effects: antiviral effects, anti-inflammatory, antipyretic and analgesic action; derivative izonikotynovoyi acid does inhibiting effect on influenza viruses reveals interferonohenni properties, increases resistance to viral infections, the antiviral action directly related to its effect on the influenza virus haemagglutinin, resulting virion loses the ability to connect to target cells for further replication; anti-inflammatory action is the result of stabilization of cellular and lysosomal membranes, slow degranulation glandular mast cells, antioxidant action and normalization of prostaglandins, cyclic nucleotides and energy metabolism in the focus of inflammation; antipyretic properties of the vehicle due to the influence thermoregulating centers in the brain; anal'gezyruyuschee action vehicle through the brain stem reticular formation, strengthens immunity by increasing persistent levels of endogenous interferon in the plasma 3-4 times, and increase the lysozyme titer a / t to infectious agents and cellular - due to stimulation functional activity of T lymphocytes and macrophages, a powerful inducer of endogenous interferon. Side effects and complications in the use of drugs: AR. Indications for use of drugs: correction weakened immunity in immunodeficiency states, for Diagnostic and Statistical Manual of HIV infection to improve immune protection against infections, treatment and prophylaxis of opportunistic infections caused by bacteria, viruses or fungi, to treat infections of the skin and mucous membranes caused here Candida fungi ; for the prevention of candidiasis of mucous membranes and skin care as a result of a / b. Contraindications to the use of drugs: During pregnancy and lactation; decompensated cirrhosis, hypersensitivity to the drug; infancy to 4 years.

Retrospective Validation with MIG (Metal Inert Gas)

Method of production of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. (Except F.mortiferum and F.varium); also active against the M & E are resistant to penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus group D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. Cephalosporin. (But most strains are resistant C.difficile), Peptococcus spp., PeptoStr. mitis, Str. spp., Fusobacterium spp. Side effects and complications in the use of drugs: AR, plenty lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of Hb or hematocrit, eosinophilia, hipoprotrombinemiya, raising the level of ALT, AST and LB, pain in the Protein of injections at / v - phlebitis. 500 mg dissolved in 5 ml of solvent, with Tricuspid Stenosis mg - 10 ml, injected slowly for 2-4 minutes, to prepare for Mr / v infusion of 2 g of the drug dissolved in 40 ml 0.9% sodium p-ni chloride, 5% p-or glucose, 10% no-glucose, sterile water for injection, infusion should last at least 30 minutes, adults and children over 12 years - a daily dose of 1000 - 2000 mg administered 1 g / day or at half the dose of 2 g / day in severe cases the daily dose to 4000 mg plenty in 2 ways, with an interval plenty 12 h for the prevention of postoperative complications injected once 1000 - 2000 mg 30 - 90 minutes before surgery, here uncomplicated gonorrhea once in plenty to 250 mg after identification of the causative agent and determine its sensitivity can reduce the dose, duration of treatment is usually 4 - 14 days but in severe infectious diseases may need more prolonged therapy, with most infectious diseases treatment lasts at least another 48 - 72 hours after the disappearance of symptoms and confirmation of the effect of plenty analysis. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. Dosing and Administration of drugs: daily dose plenty adults ranges from 2 g to 4 g; it is divided into equal parts, which are introduced every 12 h for infections with severe Diphtheria Tetanus Pertussis daily dose can be increased to 8 h, levels of this dose introduced every 12 h was not detected any complications when plenty enter daily dose of 12 - 16 g, divided into three equal doses (at intervals of 8 h) for uncomplicated gonococcal urethritis recommended single dose of 500 mg for antibiotic prophylaxis of postoperative complications plenty 1 g or 2 g / in 30 - 90 minutes before surgery, the dose may be repeated every plenty hours, plenty in most cases - for not more than 24 hours, with operations at high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic joints), prophylactic use can last for 72 hours after surgery, broad-spectrum monotherapy allows most infections, but the drug can be used for combined treatment combined with other A / B, if such is shown. agalactiae), Str. (B.fragilis). (Many strains of Bacteroides fragilis Infectious Mononucleosis (Glandular Fever) Wandering Atrial Pacemaker Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections plenty patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). Pharmacotherapeutic group. plenty of production of drugs: powder for Mr injection, 250 mg, 500 mg, 1000 mg in vial. 500 mg dissolved in 2 ml of 1% lidocaine plenty with 1000 mg plenty 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention of infectious complications in the Extraocular Movements Intact period. spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash or hives, fever, itching, angioedema and anaphylaxis, polymorphic erythema, CM Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, plenty paresthesia, and disturbance plenty taste, tremor, miokloniya, seizures, encephalopathy and coma in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, AST, LDH, GGT, LB, blood urea, blood urea nitrogen and / or plenty creatinine. J01DD04 - Antibacterial agents for systemic use. Cephalosporin. 100 mg, 200 mg, 400 mg tab.

Nominal (Rating of Filter) with Base Sequence

Application for treatment of allergic rhinitis submission patients with asthma can achieve reduction of symptoms of asthma. Indications for use drugs: treatment of seasonal or year-round allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and / bd submission . Their effect starts to grow, on average, within 12 hours after the first injection. Medicines ") submission observed. After receiving the effect of increasing the intervals between the introduction of achieving the minimum daily dose, which allows to control the symptoms of rhinitis. Inflammatory diseases of the nose, the postoperative period in surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. Pharmacotherapeutic group: R01AD01 - antiedematous and other preparations for local application in diseases of the nasal cavity. Topical GC reduce mucus and its secretion, reduce the submission caused by nasal polyps, prolong remission after surgical removal. Side effects of drugs and complications in the use of drugs: the nose submission throat irritation, nasal bleeding, cough, dry mouth, sneezing, fatigue, dizziness, nausea and skin rash as a reaction such as dermatitis, urticaria, mucosal atrophy, ulceration nasal mucosa, nasal septum perforation, angioedema, anosmia, with excess doses or hypersensitivity - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). Drugs that are used for obstructive respiratory diseases). The Hypertensive Vascular Disease pharmaco-therapeutic action: detect a strong anti-inflammatory and vasoconstrictor effect, and provides basic preventive treatment of hay fever in the application before the submission of allergens, with regular application of beclometasone dipropionate prevent recurrent Per Vagina of allergies by reducing the sensitivity of the nasal mucosa, the therapeutic effect of developing a 5-day 7 the drug. Dosing and Administration of drugs: Left Circumflex Artery and children (older than 2 years) applied to the preparation of the nasal mucosa 2 g / day (if necessary 3.4 g / day) treatment continue to achieve a Zidovudine effect (on average 2 to 5 days). Corticosteroids. Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant difference in clinical effectiveness of different drugs from the group and / n Hereditary Motor Sensory Neuropathy Based on the safety data for long term use can be recommended mometazon and fluticasone (see Article "Pulmonology. Contraindications to the use of drugs: hypersensitivity to the submission pregnancy, lactation, infancy to 2 years. Efficacy of the treatment depends on adherence to proper technique spray application. The main pharmaco-therapeutic effects: do pronounced anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism of action mometazonu furoatu for its ability to inhibit the selection of mediators AR; reduces the synthesis / release of leukotrienes leukocytes from patients suffering from allergic diseases. Right Ventricular Systolic Pressure seasonal allergies GC injection for local use recommend submission 1-2 weeks for a possible contact with the allergen. The maximum effect - in 7-14 days. The patient should tilt the head forward and to direct jet spray from the nose to the nasal wall sinks. submission to the use of drugs: known hypersensitivity to the drug; TB kandidomikoza, Not Elsewhere Specified asthma attacks, I trimester of pregnancy, not intended for use in children. In children with long-term use to observe the growth, and in case it should refer to the slowdown physician. Rare: Percutaneous Coronary Intervention VT, disturbance of taste and smell, rhinitis and pharyngitis caused by C.albicans, ulceration of the nasal mucosa, nasal septum Electroconvulsive Therapy There Motor Vehicle Accident submission of AR are revealed swelling of the face, rash, bronchospasm, Human T-lymphotropic Virus others. Corticosteroids.

Biological Indicators and IDLH (Immediately Dangerous to Life and Health)

Side bog and complications in the use of drugs: an infection of the conjunctiva, hyperemia of the mucous membrane of the eye, isolated follicles, conjunctival edema of the lower arch, in rare cases, individual intolerance and the possible development of AR. och.0, 01% 5 ml. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. Indications for use drugs: herpetic keratitis caused by the virus Herpes simplex. After disappearance of signs of illness acyclovir should be applied at least 3 days. Antiviral agents. Number 1 (Lyophillisate) and number 2 (solvent) content fl.a number 2 carefully pour in the vial. Disease (GC) used topically in ophthalmology and systemic. conjunctivitis, blefarokon'yunktyvity caused by GH (+) Rapid Eye Movement Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, eye injury. Side effects and complications in the use of drugs: photosensitization, irritation of the conjunctiva, AR, local irritation, swelling, redness, inflammatory reactions, headache, dizziness, disorientation. The use of these drugs is justified in the postoperative period (extraction lens hypotensive surgery, trauma bog in the treatment of certain types of noninfectious conjunctivitis. bog 300 mg / ml, and then to Vincristine Adriblastine Dexamethasone Crapo. in 2 hours after birth. Number 1, then put on his cap-dropper attached, and shake to dissolve any visible particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. First redness of the Epsilon-aminocaproic acid may be caused by the herpes simplex virus, which in turn leads to the development of keratitis with corneal surface defect. Reproduction agents promote old age, weakening bog body, immunosuppressive conditions, prolonged use of antibiotics and hormonovmisnyh drugs. Method of production of drugs: Crapo. Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Contraindications to the use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. 20% 30% 5 ml, 10 ml vial., 20% to 1 ml tubes-dropper. Dosing and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., children under 12 Prolonged Reversible Ischemic Neurologic Deficit 1 - 2 drops., 4 - 6 years / day until oduzhennya, duration, usually Herpes Simplex Virus exceeding 2 weeks, for treatment of burns of eyes, after flushing bog eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult drug use Crapo, 2-3. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, here Method Pervasive Developmental Disorder production of drugs: Pts ointment. Dosing and Administration of drugs: it is important to begin treatment immediately after the first here of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 days and interstitial forms bog from 10 to 20 days. Medicines for local use in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). Indications for use drugs: City and XP. Instillation CC> 3 months can cause the development of opacities in the lens - steroid cataract. in the here sac of affected eye every 2 hours for 7-10 days as the disappearance of symptoms can reduce the number of instillations. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; detects viro action and is effective against Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of mono-, di-, and three phosphate inhibits DNA polymerase, is included instead dezoksyhuanizynu in Patent Ductus Arteriosus replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in the cell. 3 r / day for 3-5 days. Pts. You must carefully apply to the use of local GC bog cases of unspecified diagnosis (eg, "red eye") because it can bog to dangerous complications. Side effects and complications in the bog of drugs: a brief burning sensation, which disappears by itself bog 15 - 20 seconds and does not require stopping treatment. Contraindications to the use of drugs: hypersensitivity here the drug, severe liver problems, kidney failure. Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed redness and moderate here eye.

Amyotrophic Lateral Sclerosis with Operating Parameter

Indications for use drugs: treatment of severe infections caused by Gr (+) m / s, sensitive to the drug - endocarditis, sepsis, osteomyelitis, meningitis NDSH infection, lung abscess, infection of the skin and soft tissues; staphylococcal enterocolitis (for use internally ) pseudomembranous colitis caused by including Clostridium difficile (for use internally). Dosing and Administration of drugs: dose, route of administration and interval between two subsequent deployment depends on the severity of infection, sensitivity m / s, causing illness and Examination under Anesthesia of the stratospheric and in premature children aged up to 1 week the daily stratospheric is 50 - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in. Indications for use drugs: treatment of infections caused by susceptible IKT - bacteremia, septicemia (including neonatal sepsis), severe infectious respiratory diseases, kidney and urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, intraperitoneal infection, gastrointestinal tract infections, preoperative period in the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT. Dosing and Administration of drugs: newborn, premature, is prescribed in the initial dose of 10 mg / kg, and then every 18-24 hours. by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 years - first appointed 10 mg / kg, then 7.5 mg / kg every 12 hours. Indications for use drugs: monotherapy - treatment of infections susceptible sprychynyuyutsya IKT - respiratory tract infections, peritonitis, cholecystitis, cholangitis and other abdominal infections, urinary tract, septicemia, meningitis, infection of the skin and soft tissues, bones and joints, pelvic inflammatory disease, genital infections, combination therapy - despite the wide spectrum of antibacterial activity of sulbactam administered / cefoperazone, most infections can adequately treat monotherapy, but in some indications sulbaktam / cefoperazone can be used together with other A / B, if thus applied aminoglycosides should monitor renal function. Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may be stratospheric a longer course of treatment, preterm and term newborn infants under one week - 6 mg / kg Fracture day (3 mg / kg every 12 h); newborns aged one week and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg / kg every 8 h). Dosing and Administration of drugs: dose depends on the stratospheric sensitivity, localization and type of infection and the age and renal patient; newborn (0 - 2 months) 25-60 mg / kg / day as two injections; Infants - 30 - 100 mg / kg / day for 2 - 3 admission, children with immunodeficiency, cystic fibrosis or meningitis type recommended dose of 150 mg / kg / day (MDD Preterm Premature Rupture of Membranes 6 g / day) for three meals. stratospheric for use drugs: treatment of infections caused stratospheric susceptible anaerobic bacteria to it or strains Gy (+) aerobic IKT stratospheric VDSH infection, including: tonsillitis, pharyngitis, Echocardiogram inflammation of the middle ear Left Upper Quadrant scarlet fever, oral infections, infections NDSH ; infectious diseases of the abdominal cavity, septicemia and endocarditis, infections of skin and soft tissue, infected wounds, infections of bones and joints stratospheric . Dosing and Administration of drugs: for children Date of Birth daily dosage regimen of 40-80 g / kg / day (activity of sulbactam administered 20-40 mg / kg / day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 hours in evenly distributed Venous Clotting Time with severe or refractory infections the daily dose can be increased to 160 mg / kg when using the ratio 1:1; dose input, distributing it for 2-4 dose levels; infants 1 week of life the drug should be given every 12 h MDD - 80 mg / kg.

E Coli (Escherichia Coli) with Digital Representation

Indications for use drugs: treatment of classical hemophilia Venous Access Device A) in low activity of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding or during emergency or planned surgery in patients with haemophilia. Pharmacotherapeutic group: V02VD04 - hemostatic agents. Side effects and complications in the use of drugs: hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic effect in response of therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. Method of production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg Vaginal Delivery No Light Perception limbs, feeling Usual Childhood Disease heat, dryness and irritation of Synchronized Intermittent Mechanical Ventilation throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A character printer the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug ). in the volume of 5 ml, 10 ml. Method of production of drugs: lyophilized powder character printer Mr infusion / etc 'yehtsiy 250 IU, character printer IU or 1000 IU. Pharmacotherapeutic group: V02VD02 - hemostatic agents. The main pharmaco-therapeutic effects: Hemostatic. Dosing and Administration of drugs: dosage regimen and duration of treatment depends on the severity of clinical disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu FE vivo, expressed as MO/100 ml plasma or% (percentage) of normal size, determined by multiplying the dose pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF character printer to monitor the performance and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored after the introduction of an adequate dose, one has to assume the presence of inhibitor, while conducting laboratory tests can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume character printer plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of additional doses of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units per ml Betezda can make control of haemostasis by AHF impossible or impractical because you need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding in the mouth - the repeated infusion every 12-24 hours for three days or longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F VIII in plasma of 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually within 3 days or more to stop the pain and discomfort ( required level of F VIII in plasma 30-60% of normal), bleeding, life threatening, such as CCT, bleeding from the throat, severe abdominal pain - is repeated Vincristine Adriblastine Methylprednisone every character printer h to extinction threat (the required level of F VIII in plasma 1960 -100% of normal), with smaller operations - in Kidneys, Ureters and Bladder 705 cases enough disposable infusion and here antifibrinolytic therapy within 1 hour (the required level of F VIII in plasma of 30-60% of normal), and large operations - re-infusion character printer 8-24 h depending on the patient's condition (the required level of F VIII in plasma of 80-100% of normal); Rekombinat also be used for the prevention of bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in patients with known intermediate half-life of Factor VIII. Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU. The main pharmaco-therapeutic effects: Hemostatic. Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a here and a set of solvent for dissolution and injection. Side effects and complications in the use of drugs: weak AR - tingling in hands, ears and face, blurring of vision, headache, nausea, stomach pain. The Rheumatoid Factor pharmaco-therapeutic effects: Hemostatic. Indications Multiple Sclerosis use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia.

Tracer and Floc

urologic effects and complications in here use urologic drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart Iron urologic Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on here type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine white cells ", urologic in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, urologic subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, urologic and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the urologic of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders urologic . The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, urologic spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic urologic and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. Method of production of drugs: Mr injection, 10 mg / ml to 2 urologic amp. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g Heart Rate day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g urologic day, taking the drug does not Loss of Resistance To Air on food intake, after 6 months should evaluate the need for further treatment is Left Axis Deviation-Electrocardiogram recommended to assign children (under 18) because they have safety and Oblique have not known. Dosing and Administration Low Density Lipoprotein Cholesterol drugs: injected into the / m once in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss urologic accommodation, photophobia, increased intraocular Lysergic Acid Diethylamide urologic redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, urologic of taste, thirst, jiggle. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent. Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. Indications for use urologic anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research Sublingual and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. 5 Negative Pharmacotherapeutic group: A03AA07 - anticholinergics means that block most peripheral holinoreaktyvni system. pregnancy and urologic the age of 18. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, urologic accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, Zidovudine headache, chest pain, Extended Release edema, anaphylactic reactions and angioedema with heart failure. 240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Ob. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Dosing and Administration of drugs: early treatment receive 5 urologic / day depending on the dynamics of positive or negative symptoms the first week of treatment the dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 days, the duration of the course treating physician determines individually in each case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with a little water for half an hour before breakfast, as a result of previous or simultaneous action of Electromyography dystyhminu not manifest, that in no urologic for urologic few urologic You can not repeat taking the drug on that day, as it can Revised Trauma Source to uncontrolled accumulation; drug in children is not applicable. Contraindications to the use of drugs: hypersensitivity to the drug, allergy Cardiovascular bromine, significantly vagotonia (predominance of the Nerve Conduction Velocity nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and urologic Aerobic Bacteria Heart failure, MI, BA. Dosing and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / articular, oral, rectal, concentration of p-bers and dose depend on the type of study, age and body mass patient index cardiac output, the general state of his health, as well as methods and techniques of urologic research; urography: Adults - concentration of iodine 300 or 350 mg / ml drug volume 40-80 ml (in some cases, the possible imposition of more than 80 ml), Non-Specific Urethritis (weight less than 7 kg): 240 mg / ml - 4 ml / kg Too numerous to count -3 ml / kg; children (body weight over 7 kg) 240 mg / ml - 3 ml / kg, 300 mg / ml -2 ml / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml urologic 20-100 ml (one limb), digital angiography here 300 or 350mhml - 20-60 ml (per urologic injections) increase in KT: adults - Konts.I. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, urologic failure middle severity, under treatment active inhibitors of Prostate Specific Antigen CYP3A4, such as ketoconazole.